P14.17 What is the optimal therapeutic strategy for limited brain metastases (BMs) from non small cell lung cancer (NSCLC)? Prognostic factors conditioning brain control and patients outcome | Zendy

AI Assistant Blog Pricing

P14.17 What is the optimal therapeutic strategy for limited brain metastases (BMs) from non small cell lung cancer (NSCLC)? Prognostic factors conditioning brain control and patients outcome

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.